![Nick Leschly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nick Leschly
Directeur Général chez
FierceBiotech
Profil
Nick Leschly a fondé Medxtend Corp. Actuellement, il occupe le poste de président, directeur général et directeur de bluebird bio, Inc. et directeur général de FierceBiotech. Il est également membre du conseil d'administration de Biotechnology Innovation Organization, Synlogic Operating Co., Inc. et Synlogic, Inc. Dans sa carrière antérieure, il a été directeur général de Medxtend Corp, directeur commercial d'Agios Pharmaceuticals, Inc. et associé de Third Rock Ventures LLC. Nick Leschly a obtenu un diplôme de premier cycle à l'université de Princeton et un MBA à la Wharton School de l'université de Pennsylvanie.
Postes actifs de Nick Leschly
| Sociétés | Poste | Début |
|---|---|---|
FierceBiotech
 FierceBiotech Commercial Printing/FormsCommercial Services Publishes magazines and articles | Directeur Général | 21/04/2011 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | - |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur/Membre du Conseil | 23/03/2016 |
Synlogic Therapeutics | Directeur/Membre du Conseil | - |
Anciens postes connus de Nick Leschly
| Sociétés | Poste | Fin |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Directeur Général | 04/11/2021 |
| 2SEVENTY BIO, INC. | Directeur Général | 01/04/2024 |
| SYNLOGIC, INC. | Directeur/Membre du Conseil | 10/01/2025 |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Private Equity Investor | 30/06/2009 |
Medxtend Corp. | Directeur Général | 01/03/2001 |
Formation de Nick Leschly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Proclara Biosciences, Inc.
 Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Provides treatment of chronic neurodegenerative diseases | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FierceBiotech
FierceBiotech Commercial Printing/FormsCommercial Services Publishes magazines and articles | Commercial Services |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Finance |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for improving the health and quality of life of families living with XLHED | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Synlogic, Inc.
 Synlogic, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Medxtend Corp. | |
2seventy Bio, Inc.
 2seventy Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for the treatment of cancer and genetic diseases | Health Technology |
Synlogic Therapeutics |
